Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamorelin SC vs IM in Advanced Prostate Cancer
NCT00444639Phase 2Terminated
- Sponsor
- Ipsen
- Start
- Feb 2007
- Primary completion
- Feb 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triptorelin in prostate cancer (PCa), sponsored by Ipsen. Started Feb 2007; status: terminated.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00444639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444639.